Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin gastric inhibitory polypeptide, and gastrin-17 in dogs.
D000818:Animals; D002766:Cholecystokinin / Q000494:pharmacology*; D004285:Dogs; D005749:Gastric Inhibitory Polypeptide / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000378:metabolism*; D005755:Gastrins / Q000494:pharmacology*; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D005934:Glucagon / Q000097:blood; D007328:Insulin / Q000097:blood; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D012633:Secretin / Q000494:pharmacology*; D013004:Somatostatin / Q000097:blood / Q000378:metabolism*; D013270:Stomach / Q000187:drug effects
D005755:Gastrins; D005768:Gastrointestinal Hormones; D007328:Insulin; D012633:Secretin; D013004:Somatostatin; D005749:Gastric Inhibitory Polypeptide; D005934:Glucagon; D002766:Cholecystokinin